Lazard Asset Management LLC Lowers Position in Agilent Technologies, Inc. $A

Lazard Asset Management LLC decreased its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 2.0% in the 1st quarter, HoldingsChannel.com reports. The firm owned 756,599 shares of the medical research company’s stock after selling 15,753 shares during the quarter. Lazard Asset Management LLC’s holdings in Agilent Technologies were worth $86,237,000 at the end of the most recent quarter.

Other large investors also recently bought and sold shares of the company. Brighton Jones LLC boosted its holdings in shares of Agilent Technologies by 6.1% in the 4th quarter. Brighton Jones LLC now owns 4,663 shares of the medical research company’s stock valued at $626,000 after purchasing an additional 270 shares during the last quarter. Jones Financial Companies Lllp increased its holdings in shares of Agilent Technologies by 15.9% during the 1st quarter. Jones Financial Companies Lllp now owns 5,610 shares of the medical research company’s stock worth $602,000 after buying an additional 769 shares during the last quarter. Geneos Wealth Management Inc. increased its holdings in shares of Agilent Technologies by 54.8% during the 1st quarter. Geneos Wealth Management Inc. now owns 599 shares of the medical research company’s stock worth $70,000 after buying an additional 212 shares during the last quarter. Acadian Asset Management LLC raised its position in shares of Agilent Technologies by 16.5% in the 1st quarter. Acadian Asset Management LLC now owns 5,352 shares of the medical research company’s stock worth $625,000 after buying an additional 758 shares during the period. Finally, Sivia Capital Partners LLC purchased a new position in shares of Agilent Technologies in the 2nd quarter worth $273,000. Hedge funds and other institutional investors own 87.41% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages recently weighed in on A. Robert W. Baird lifted their target price on Agilent Technologies from $155.00 to $156.00 and gave the company an “outperform” rating in a report on Tuesday, May 26th. Bank of America upgraded Agilent Technologies from a “neutral” rating to a “buy” rating and cut their price objective for the stock from $150.00 to $145.00 in a report on Thursday, May 28th. Sanford C. Bernstein started coverage on Agilent Technologies in a research note on Friday, June 26th. They issued an “outperform” rating and a $155.00 price objective on the stock. TD Cowen boosted their target price on Agilent Technologies from $147.00 to $155.00 and gave the stock a “buy” rating in a report on Thursday, May 28th. Finally, Wolfe Research reissued a “hold” rating on shares of Agilent Technologies in a research report on Tuesday, June 2nd. Two equities research analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and four have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $159.35.

Agilent Technologies Stock Down 0.4%

Shares of Agilent Technologies stock opened at $138.07 on Tuesday. Agilent Technologies, Inc. has a twelve month low of $108.35 and a twelve month high of $160.27. The stock has a market cap of $39.00 billion, a price-to-earnings ratio of 27.73, a price-to-earnings-growth ratio of 2.46 and a beta of 1.25. The company has a current ratio of 2.10, a quick ratio of 1.62 and a debt-to-equity ratio of 0.43. The company has a fifty day moving average price of $130.27 and a 200 day moving average price of $125.36.

Agilent Technologies (NYSE:A) last released its quarterly earnings data on Wednesday, May 27th. The medical research company reported $1.49 EPS for the quarter, beating the consensus estimate of $1.41 by $0.08. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The company had revenue of $1.83 billion for the quarter, compared to analyst estimates of $1.80 billion. During the same period last year, the company posted $1.31 earnings per share. The firm’s revenue was up 10.0% compared to the same quarter last year. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Equities research analysts forecast that Agilent Technologies, Inc. will post 6.01 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Wednesday, July 22nd. Stockholders of record on Tuesday, June 30th were paid a $0.255 dividend. The ex-dividend date was Tuesday, June 30th. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.7%. Agilent Technologies’s dividend payout ratio (DPR) is 20.48%.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.